Distributions of latencies of patients with t-AML in the combined UC and UK series stratified by MDM2 genotype and sex
| Genotype . | No. of patients . | Latency, mo . | P . | |
|---|---|---|---|---|
| Median . | IQR . | |||
| Women | .11 | |||
| TT | 34 | 79 | 34-139 | |
| TG | 34 | 66 | 25-96 | |
| GG | 11 | 41 | 22-108 | |
| Total | 79 | 64 | 28-129 | |
| Men | .96 | |||
| TT | 21 | 56 | 38-118 | |
| TG | 27 | 84 | 36-120 | |
| GG | 9 | 47 | 31-122 | |
| Total | 57 | 59 | 36-120 | |
| Genotype . | No. of patients . | Latency, mo . | P . | |
|---|---|---|---|---|
| Median . | IQR . | |||
| Women | .11 | |||
| TT | 34 | 79 | 34-139 | |
| TG | 34 | 66 | 25-96 | |
| GG | 11 | 41 | 22-108 | |
| Total | 79 | 64 | 28-129 | |
| Men | .96 | |||
| TT | 21 | 56 | 38-118 | |
| TG | 27 | 84 | 36-120 | |
| GG | 9 | 47 | 31-122 | |
| Total | 57 | 59 | 36-120 | |
IQR indicates interquartile range.